MECOM and acute myeloid leukemia: Significantly higher MECOM mRNA levels were detected in the AML patients compared to the healthy donors (Fig 6E, left), while miR-22 levels were much lower in the same AML samples compared to the healthy donors (Fig 6E, middle).